From The Industry Experts

  1. Contracting For AI In Clinical Trials: Data Rights And Regulatory Compliance (Part 2) 5/15/2026

    Leibowitz Law's three-part series examines how AI is being used in clinical trial operations and the contractual and operational risks that follow. Part 2 demonstrates why organizations must understand where it is used, how it interacts with data, and where the risks lie.

  2. Where AI Appears In Clinical Trials — And Why Contracts Need To Catch Up (Part 1) 5/15/2026

    Leibowitz Law's three-part series examines how AI is being used in clinical trial operations and the contractual and operational risks that follow. Part 1 outlines where AI appears in ClinOps and supporting technologies, and the questions companies and organizations should ask when AI touches data.

  3. Designing Trials Patients Can Actually Complete: Lessons From The SWIFT Deep TMS Study 5/15/2026

    Being time conscious and attuned to patient needs are two contributing factors to trials that recruit and retain patients for the duration.

  4. It's A Fact: Sharing Clinical Trial Results With Participants Builds Trust 5/14/2026

    CISCRP experts share results from their annual Perceptions & Insights Study showing that patients continue to place a high value on receiving both individual and overall study results.

  5. Reduce Avoidable Protocol Amendments By Anticipating Operational Pitfalls 5/13/2026

    This report examines how amendment drivers vary across therapeutic areas and how those changes impact execution, patient burden, site workload, timelines, and study costs.

  6. What Sponsors Need To Know Before They Get To The IRB & IBC 5/13/2026

    Gene therapy requires early, rigorous safety planning and command of pediatric and biosafety rules. Early committee engagement reduces delays and strengthens high‑stakes trials.

  7. When AI Agents Start Researching Trials On Behalf Of Patients, What Happens? 5/13/2026

    Right now, patients are using AI agents to find clinical trials. But soon enough, these AI tools will be doing it on their own and feeding patients the results. Recruitment expert Ross Jackson discusses this shift and what it will mean for sponsors.

  8. 5 Questions Sponsors Must Ask Before Selecting A Randomization Partner 5/12/2026

    Choose the right IRT partner for complex master protocols. Learn how adaptive randomisation expertise and flexible technology reduce disruption and keep trials execution-ready.

  9. Retention And Access In NSCLC Clinical Trials 5/12/2026

    Helping participants navigate respiratory limitations, fatigue, and complex visit schedules in Non-Small Cell Lung Cancer (NSCLC) studies.

  10. When Participants Need Help, Someone's Got To Respond 5/12/2026

    Support for clinical trial participants helps you ensure requests are handled clearly and in line with study guidelines by managing travel, reimbursements, and logistics.